ZYME
Latest News for ZYME
An update from Zymeworks ( ($ZYME) ) is now available. Zymeworks announced its participation in upcoming conferences, including the ASCO Gastrointe......
Zymeworks ( ($ZYME) ) just unveiled an update. Zymeworks Inc. announced its participation in upcoming investor conferences, including the Evercore ......
LifeSci Capital analyst Charles Zhu maintained a Buy rating on Zymeworks today and set a price target of $34.00. Zhu covers the Healthcare sector, ......
In a report released yesterday, Jonathan Miller from Evercore ISI reiterated a Buy rating on Zymeworks, with a price target of $33.00. Miller cover......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zymeworks (ZYME – Research Report) and Medtronic (......
Zymeworks ($ZYME) stock rallied 29% on Monday, after the clinical-stage biotechnology company announced positive Phase 3 trial results for its gast......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Zymeworks (ZYME – Research Report), MBX Biosciences, Inc. (MBX – ......
Zymeworks ( ($ZYME) ) just unveiled an update. In its third-quarter 2025 update, Zymeworks reported significant progress in its clinical trials and......
News data is sourced from MarketXLS API and updated regularly.
Showing 8 of 8 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZYME | $26.58 | +1.4% | 333.30K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |